Detection of Subclinical Enthesitis by Ultrasonography
NCT04209894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61
Last updated 2023-06-26
Summary
Detection of subclinical enthesitis by ultrasonography
Conditions
- Enthesitis
Interventions
- DIAGNOSTIC_TEST
-
Ultrasound
Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas of participants. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities
Sponsors & Collaborators
-
Fatih Sultan Mehmet Training and Research Hospital
lead OTHER
Principal Investigators
-
Duygu Silte Karamanlioglu, MD · Fatih Sultan Mehmet Training and Research Hospital
-
Feyza Unlu Ozkan, Prof. · Fatih Sultan Mehmet Training and Research Hospital
-
Eylem Ceren Arikan, MD · Fatih Sultan Mehmet Training and Research Hospital
-
Betül Zehra Pirdal, MD · Istanbul Sultangazi District Health Directorate
-
Gulcan Ozturk, MD · Fatih Sultan Mehmet Training and Research Hospital
-
Ilknur Aktas, Prof · Fatih Sultan Mehmet Training and Research Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-15
- Primary Completion
- 2023-02-15
- Completion
- 2023-03-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Efficacy of Upadacitinib After NECS in Vitiligo
NCT06454461 ·Status: RECRUITING ·Phase: NA
-
A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
NCT02307513 ·Status: COMPLETED ·Phase: PHASE3
-
The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis
NCT02627209 ·Status: UNKNOWN ·Phase: NA
-
Ustekinumab for the Treatment of Giant Cell Arteritis
NCT02955147 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
NCT06721234 ·Status: RECRUITING
-
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
NCT04161898 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
NCT04105439 ·Status: UNKNOWN
-
IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)
NCT05128357 ·Status: UNKNOWN
-
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
NCT01730495 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
NCT03725202 ·Status: COMPLETED ·Phase: PHASE3
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Central China Rosai-Dorfman Disease Registry
NCT05284942 ·Status: UNKNOWN ·Phase: PHASE4
-
Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
NCT00974883 ·Status: COMPLETED
-
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
NCT05894512 ·Status: COMPLETED
-
Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy
NCT04554290 ·Status: COMPLETED
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Macrophage Activation syndromE in STill's Disease in Italy
NCT06992505 ·Status: COMPLETED
-
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
NCT04882072 ·Status: TERMINATED ·Phase: PHASE3
-
A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
NCT04509570 ·Status: COMPLETED ·Phase: NA
-
Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
NCT04012905 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
NCT07276087 ·Status: RECRUITING
-
Ustekinumab in BEhçet's Syndrome STudy
NCT07244614 ·Status: RECRUITING
-
Evaluation Of Non Infectious Presentation of Inborn Errors Of Immunity
NCT05870410 ·Status: UNKNOWN
-
Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis
NCT02874586 ·Status: UNKNOWN ·Phase: NA